Home / Olmesartan Medoxomil and Diuretics / Italy
IT ATC C09DA08 · updated 2 Nov 2026
Olmesartan Medoxomil and Diuretics shortage in Italy
Is there an Olmesartan Medoxomil and Diuretics shortage in Italy?
Yes. As of 2 Nov 2026, 11 Olmesartan Medoxomil and Diuretics products are reported short in Italy, the first since 31 Aug 2023. No return date has been given. Main reason: manufacturing problem.
Also short in Canada, Spain, Belgium. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | OLMESARTAN E IDROCLOROTIAZIDE ZENTIVA | ZENTIVA ITALIA S.R.L. | 31 Aug 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN E IDROCLOROTIAZIDE ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Sep 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN E IDROCLOROTIAZIDE ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Nov 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 16 Sep 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 30 Sep 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 9 Dec 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN E IDROCLOROTIAZIDE AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 8 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMEGAN anticipated | DAIICHI SANKYO ITALIA S.P.A. | 30 Nov 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLMEGAN anticipated | DAIICHI SANKYO ITALIA S.P.A. | 30 Dec 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLMEGAN anticipated | DAIICHI SANKYO ITALIA S.P.A. | 30 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMEGAN anticipated | DAIICHI SANKYO ITALIA S.P.A. | 30 Dec 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.